Literature DB >> 26379929

LMNA gene single nucleotide polymorphisms in dilated cardiomyopathy of Han children.

Li-Jian Xie1, Ting-Ting Xiao1, Min Huang1, Jie Shen1.   

Abstract

OBJECTIVE: To investigate whether LMNA gene mutation is associated with dilated cardiomyopathy (DCM) in Chinese Han Race children.
METHODS: DNA was isolated from 78 patients with DCM and 100 healthy Chinese children who served as controls. 12 exons in the functional regions and the adjacent part of introns of the LMNA gene were amplified with polymerase chain reactions (PCR) and the PCR products were sequenced with DNA sequencer. We compared the DNA sequence with Blast software online PubMed website. The differences of allele and genotype between the groups were detected by χ(2) test.
RESULTS: No disease-causing mutation in LMNA gene was found in all DCM patients. Three nonsense single nucleotide polymorphisms (SNPs) were identified. ① The first is c.1908C>T (H566H, rs4641) which was located at exon 10 of LMNA gene. It was found in 29 DCM cases and 15 control subjects. Compared to healthy controls, the frequency of TT and TC genotypes, and the C allele were significantly increased in DCM patients (P<0.05). ② The second was c.861C>T (A287A, rs5380) which was located at exon 5 of LMNA gene. It was found in 9 DCM cases and 2 control subjects. The frequency of TC genotype was significantly increased in DCM patients (P<0.05). ③ The third was c.1338C>T (D446D, rs5058) which located at exon 7 of LMNA gene. It was found in 8 DCM cases and 3 control subjects. The frequency of TC genotype was significantly increased in DCM patients (P<0.05).
CONCLUSION: The SNP of LMNA gene may be associated with the susceptivity of DCM in Chinese Han children.

Entities:  

Keywords:  Dilated cardiomypathy; LMNA gene; single nucleotide polymorphisms

Year:  2015        PMID: 26379929      PMCID: PMC4565312     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  12 in total

Review 1.  Nuclear envelope proteins and neuromuscular diseases.

Authors:  Cecilia Ostlund; Howard J Worman
Journal:  Muscle Nerve       Date:  2003-04       Impact factor: 3.217

2.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C.

Authors:  F Lin; H J Worman
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

Review 6.  Clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Emily L Burkett; Ray E Hershberger
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

7.  Lamin A/C mutations associated with familial and sporadic cases of dilated cardiomyopathy in Koreans.

Authors:  Kyuyoung Song; Marie Pierre Dubé; Jiyoung Lim; Ilsun Hwang; Inchul Lee; Jae-Joong Kim
Journal:  Exp Mol Med       Date:  2007-02-28       Impact factor: 8.718

8.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

Authors:  J Peter van Tintelen; Robert M W Hofstra; Hilga Katerberg; Tom Rossenbacker; Ans C P Wiesfeld; Gideon J du Marchie Sarvaas; Arthur A M Wilde; Irene M van Langen; Eline A Nannenberg; Anneke J van der Kooi; Marian Kraak; Isabelle C van Gelder; Dirk Jan van Veldhuisen; Yvonne Vos; Maarten P van den Berg
Journal:  Am Heart J       Date:  2007-09-14       Impact factor: 4.749

9.  Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.

Authors:  Vesna Nikolova; Christiana Leimena; Aisling C McMahon; Ju Chiat Tan; Suchitra Chandar; Dilesh Jogia; Scott H Kesteven; Jan Michalicek; Robyn Otway; Fons Verheyen; Stephen Rainer; Colin L Stewart; David Martin; Michael P Feneley; Diane Fatkin
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

10.  A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1.

Authors:  S Kass; C MacRae; H L Graber; E A Sparks; D McNamara; H Boudoulas; C T Basson; P B Baker; R J Cody; M C Fishman
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.